Fri, Jun 21, 2024
Sun Pharmaceutical Industries has announced a licensing pact with Takeda Pharmaceutical Company to commercialise a novel gastrointestinal drug in India.
More >
Wed, Nov 23, 2022
In today's edition of Traders Diary, Zee Business research team brings its exclusive research on 20 stocks that investors and traders can refer to while making their strategies in them
Tue, Nov 01, 2022
Sun Pharmaceuticals Industries stocks gained on Tuesday on positive July-September quarter estimates. The scrip quoted Rs 1034 apiece on NSE, up 1 per cent, in afternoon session. The drug maker also hit a fresh 52-week high of Rs 1047 today which also is the counter's intraday high.
Thu, Oct 13, 2022
Wipro: SELL | Downside 5% - Wipro's drop in net profit for the quarter ended 30 June 2022 was not taken well by the investors today as the stock hit its 52-week lows on the day of expiry.
Mon, Sep 05, 2022
Stock Market Today 5 September 2022: In the 30-share BSE Sensex, 24 stocks were gainers at the closing time. The remaining 6 were losers
Wed, Sep 29, 2021
Sun Pharmaceuticals – The shares of Sun Pharma today ended at Rs 790.50 on Tuesday, up 3.6 per cent from the Monday closing price. He puts target price at Rs 850-Rs 880 with a stop loss at Rs 755. The stock has seen some correction after attaining a 52-week high of Rs 804.35 on 3 August
Fri, Oct 21, 2016
Forbes’ edition of most affluent Indians, released on Friday had Mukesh Ambani, managing director of Reliance Industries on top of the charts with net worth of $22.7 billion.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
